Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F3JT
|
|||
| Former ID |
DAP000287
|
|||
| Drug Name |
Mecasermin
|
|||
| Synonyms |
Increlex (TN)
Click to Show/Hide
|
|||
| Indication | Growth failure [ICD-11: LD2F.1Y] | Approved | [1], [2] | |
| Therapeutic Class |
Immunomodulatory Agents
|
|||
| ADReCS Drug ID | BADD_D01358 | |||
| SuperDrug ATC ID |
H01AC03
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. | |||
| REF 2 | 2005 approvals: Safety first. Nature Reviews Drug Discovery 5, 92-93 (February 2006). | |||
| REF 3 | IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer. Virchows Arch. 2003 Aug;443(2):139-45. | |||
| REF 4 | One of two chondrocyte-expressed isoforms of cartilage intermediate-layer protein functions as an insulin-like growth factor 1 antagonist. Arthritis Rheum. 2003 May;48(5):1302-14. | |||
| REF 5 | Analysis of the human type I insulin-like growth factor receptor promoter region. Biochem Biophys Res Commun. 1991 Jun 28;177(3):1113-20. | |||
| REF 6 | Insulin-like growth factor I receptor gene structure. J Biol Chem. 1992 May 25;267(15):10759-63. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.